Novozymes EBIT 2011-2023 | NVZMY
Novozymes annual and quarterly EBIT history from 2011 to 2023. EBIT can be defined as earnings before interest and taxes.
- Novozymes EBIT for the quarter ending December 31, 2023 was $0.138B, a 1.74% decline year-over-year.
- Novozymes EBIT for the twelve months ending December 31, 2023 was $0.577B, a 10.61% decline year-over-year.
- Novozymes 2023 annual EBIT was $0.577B, a 10.61% decline from 2022.
- Novozymes 2022 annual EBIT was $0.646B, a 1.31% increase from 2021.
- Novozymes 2021 annual EBIT was $0.638B, a 13.95% increase from 2020.
Novozymes Annual EBIT
(Millions of US $) |
| 2023 |
$577 |
| 2022 |
$646 |
| 2021 |
$638 |
| 2020 |
$559 |
| 2019 |
$605 |
| 2018 |
$645 |
| 2017 |
$616 |
| 2016 |
$586 |
| 2015 |
$578 |
| 2014 |
$603 |
| 2013 |
$508 |
| 2012 |
$474 |
| 2011 |
$428 |
| 2010 |
$963 |
Novozymes Quarterly EBIT
(Millions of US $) |
| 2023-12-31 |
$138 |
| 2023-09-30 |
$149 |
| 2023-06-30 |
$126 |
| 2023-03-31 |
$163 |
| 2022-12-31 |
$141 |
| 2022-09-30 |
$174 |
| 2022-06-30 |
$159 |
| 2022-03-31 |
$172 |
| 2021-12-31 |
$122 |
| 2021-09-30 |
$174 |
| 2021-06-30 |
$160 |
| 2021-03-31 |
$181 |
| 2020-12-31 |
$129 |
| 2020-09-30 |
$140 |
| 2020-06-30 |
$128 |
| 2020-03-31 |
$162 |
| 2019-12-31 |
$163 |
| 2019-09-30 |
$127 |
| 2019-06-30 |
$179 |
| 2019-03-31 |
$136 |
| 2018-12-31 |
$161 |
| 2018-09-30 |
$162 |
| 2018-06-30 |
$153 |
| 2018-03-31 |
$168 |
| 2017-12-31 |
$161 |
| 2017-09-30 |
$167 |
| 2017-06-30 |
$142 |
| 2017-03-31 |
$145 |
| 2016-12-31 |
$154 |
| 2016-09-30 |
$146 |
| 2016-06-30 |
$146 |
| 2016-03-31 |
$140 |
| 2015-12-31 |
$148 |
| 2015-09-30 |
$151 |
| 2015-06-30 |
$138 |
| 2015-03-31 |
$116 |
| 2014-12-31 |
$108 |
| 2014-09-30 |
$122 |
| 2014-06-30 |
$125 |
| 2014-03-31 |
$174 |
| 2013-12-31 |
$152 |
| 2013-09-30 |
$156 |
| 2013-06-30 |
$140 |
| 2013-03-31 |
$119 |
| 2012-12-31 |
$-33 |
| 2012-09-30 |
$118 |
| 2012-06-30 |
$88 |
| 2012-03-31 |
$282 |
| 2011-12-31 |
$-384 |
| 2011-09-30 |
$120 |
| 2011-06-30 |
$112 |
| 2011-03-31 |
$493 |
| 2010-12-31 |
$438 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$26.473B |
$2.598B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
